Availability on Infomed of SmPC and PIL after the conclusion of clinical variations and renewals in which Portugal acts as an Concerned Member State (PT CMS) / MRP/DCP marketing authorisations and national marketing authorisations in MRP worksharings – Notícias
19 jul 2024 Para: Divulgação geral Contactos Centro de Informação do Medicamento e dos Produtos de Saúde (CIMI); Tel. 21 798 7373; E-mail: [email protected]; Linha do Medicamento: 800 222 444 Circular Informativa N.º 048/CD/100.20.200 Data:19/07/2024 With the aim to clarify the procedure for publishing in Infomed the summaries of product characteristics (SmPC) and package leaflets […]